期刊文献+

糖尿病人持续输注罗库溴铵后残余肌松的变化 被引量:4

Change of the residual neuromuscular blockade after infusing rocuronium in patients with diabetes mellitus
暂未订购
导出
摘要 目的观察糖尿病人持续输注罗库溴铵后残余肌松的变化。方法选择期腹部手术病人 4 0例 ,分为合并Ⅱ型糖尿病组和非糖尿病组各 2 0例 ,ASAⅡ级。全部病人肌力法肌松监测下 ,罗库溴铵诱导插管 ,吸入 0 .6 %异氟烷 ,并静脉泵注丙泊酚维持BIS 30~ 4 0 ,T1恢复至 15 %开始持续输注罗库溴铵以维持T15 %~ 15 %肌松水平 ,术毕停药后自然恢复 ,观测T1恢复至 2 5 %、5 0 %、75 %和TOF恢复至 70 %的时间及此时的T1/T0 值。结果T12 5 %、5 0 %、75 %恢复时间糖尿病组较非糖尿病组明显延长(P <0 .0 5 ) ,而TOF 70 %恢复时间两组无显著差异 (P >0 .0 5 ) ,其对应T1/T0 值观察组明显低于非糖尿病组 (P <0 .0 1)。结论对糖尿病人全麻术后拔管时机的判断不宜单纯依赖TOF ,应结合T1/T0 Objective To investigate the change of the residual neuromuscular blockade after infusing continuously rocuronium in patients with diabetes mellitus. Methods Forty patients undergoing abdominal surgery were divided into group patients with type2 diabetes mellitus (DM, n=20) and group non-diabetic patients (ND,n=20). After induction, while T 1 recover 15%, all patients began to infuse rocuronium to obtain the depth of neuromuscular block such as T 15%~15%. Record the recovery time of T 125%,50%,75% and TOF 70% by the mechanomyography, as well as simultaneity T 1/T 0. Results There were no significant differences among two groups with patients' information and the time and velocity of infusion rocuronium. Times to recovery of T 125%, 50% and 75% in group DM were significantly longer than in group ND (P<0.05).The times of recovery of TOF 70% were similar in two groups, the simultaneity T 1/T 0 in group DM were significantly lower than in the group ND. Conclusion We should judge the extubation time combining TOF and T 1/T 0 in diabetic patients.
作者 罗伟 沈伯雄
出处 《上海第二医科大学学报》 CSCD 2004年第11期958-960,共3页 Acta Universitatis Medicinalis Secondae Shanghai
关键词 糖尿病 持续输注 罗库溴铵 残余肌松 diabetes mellitus rocuronium residual neuromuscular blockade
  • 相关文献

参考文献5

  • 1Hayes AH,Mirakhur RK,Breslin DS,et al.Postoperative residual block after intermediate-acting neuromuscular blocking drugs[J].Anaesthesia,2001,56(4):312-318.
  • 2Saitoh Y,Kaneda K,Hattori H,et al.Monitoring of neuromuscular block after administration of vecuronium in patients with diabetes mellitus[J].Br J Anaesth,2003,90(4):480-486.
  • 3Khuenl-Brady KS,Sparr H.Clinical pharmacokinetics of rocuronium bromide[J].Clin Pharmacokinet,1996;31:174-183.
  • 4Atallah MM,Daif AA,Saied MM,et al.Neuromuscular blocking activity of tubocurarine in patients with diabetes mellitus[J].Br J Anaesth,1992,68:567-569.
  • 5Saitoh Y,Toyooka H,Amaha K.Recoveries of post-tetanic twitch and train-of-four responses after administration of vecuronium with different inhalation anaesthetics and neuroleptanaesthesia[J].Br J Anaesth,1993,70:402-404.

同被引文献49

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部